Obesity as a risk factor for complications in patients with COVID-19

Authors

  • Guillermo Alejandro Herrera Horta Universidad de Ciencias Médicas de Pinar del Río. Facultad de Ciencias Médicas “Dr. Ernesto Che Guevara de la Serna”. Pinar del Río https://orcid.org/0000-0002-3573-2397
  • Zurelys Gutiérrez García Universidad de Ciencias Médicas de Pinar del Río. Facultad de Ciencias Médicas “Dr. Ernesto Che Guevara de la Serna”. Pinar del Río https://orcid.org/0000-0002-0549-4359
  • Guillermo Luis Herrera Miranda Universidad de Ciencias Médicas de Pinar del Río. Pinar del Río https://orcid.org/0000-0002-5366-3030

DOI:

https://doi.org/10.5281/zenodo.7884906

Keywords:

Obesity, COVID-19, Coronavirus, Risk.

Abstract

Introduction: obesity is a disease that has been related to the pandemic of the new coronavirus, suggesting that obese people are at greater risk of suffering severe COVID-19 and its complications.

Objective: to describe obesity as a risk factor for complications and death in patients with COVID-19.

Methods: a total of 58 sources were reviewed in the Pubmed, SciELO and Ebsco databases, of which 33 citations in English, Portuguese and Spanish were used, all from the years 2020 and 2021. The search terms "obesity", "COVID-19", "mortality", "complications" were used.

Results: obese patients infected with COVID-19 are more likely to develop more severe disease, require admission to the intensive care unit and the need for ventilation, due to scientifically demonstrated biological mechanisms.

Conclusions: obesity is an independent risk factor for severe disease and death from COVID-19.

Downloads

Download data is not yet available.

References

1. OMS. Organización Mundial de la Salud [citado 16/08/2022]. De https://www.who.int/es/news-room/factsheets/detail/obesity-and-overweight

2. OMS. Organización Mundial de la Salud [citado 16/08/2022]. Disponible en: https://www.paho.org/es/noticias/11-3-2020-oms-caracteriza-covid19comopandemia#:~:text=Ginebra%2C%2011%2de%20marzo%20de,puede%20caracterizarse%20como%20una%20pandemia

3. Organización Panamericana de la Salud. Covid 19. Respuesta de la OPS/OMS. Organización Mundial de la Salud [citado 16/08/2022]. Washintong D.C.

4. Organización Mundial de la Salud [Internet]. Cronología de la respuesta de la OMS a la COVID-19‎. [Internet]. 2020 [citado 16/08/2022]. Disponible en: https://www.who.int/es/news/item/29-06-2020-covidtimeline

5. Sattar N, McInnes IB, McMurray JJV. Obesity Is a Risk Factor for Severe COVID19 Infection: Multiple Potential Mechanisms. Circulation [Internet]. 2020 [citado 16/08/2022]; 142(1):4-6. Disponible en: https://doi.org/10.1161/CIRCULATIONAHA.120.047659
.
6. Tamara A, Tahapary DL. Obesity as a predictor for a poor prognosis of COVID-19: A systematic review. Diabetes Metab Syndr Clin Res Rev [Internet]. 2020 [citado 16/08/2022]; 14(4):655-9. Disponible en: https://doi.org/10.1016/j.dsx.2020.05.020.

7. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet [Internet]. 2020 [citado 16/08/2022]; 395(10229):1054- 62. https://doi.org/10.1016/S0140-6736(20)30566-3.

8. Backes MTS, Carvalho KM, Santos EKA, Backes DS. Novo coronavírus: ¿o que a enfermagem tem a aprender e ensinar em tempos de pandemia? Rev. Bras. Enferm [Internet]. 2020 [citado 16/08/2022]; 73(Suppl 2):e20200259. Disponible en: http://dx.doi.org/10.1590/0034-7167- 2020-0259

9. Malo Serrano M, Castillo N, Pajita D. La obesidad en el mundo. An Fac Med [Internet]. 2017 [citado 20/05/2020]; 78(2):173-178. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1025-55832017000200011&lng=es

10. Organización Mundial de la Salud. La obesidad entre los niños y los adolescentes se ha multiplicado por 10 en los cuatro últimos decenios. Ginebra: OMS. Comunicado de prensa; 2017 [citado 16/08/2022]. Disponible en: https://www.who.int/es/news-room/detail/11-102017-tenfold-increase-in-childhood-and-adolescent-obesity-in-four-decades-new-study-byimperial-college-london-and-who

11. Varona-Pérez P, Gámez Sánchez D, Díaz Sánchez ME. Impacto del sobrepeso y obesidad en la mortalidad por enfermedades no trasmisibles en Cuba. Rev Cubana Med Gen Integr [Internet]. 2018 [citado 06/07/2020]; 34(3):71-81. Disponible en:
http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21252018000300009&lng=es&nrm=iso&tlng=es

12. Rakotoarivelo V, Variya B, Langlois MF, Ramanathan S. Chemokines in human obesity. Cytokine[Internet]. 2020 [citado 16/08/2022];127:154953. Disponible en: https://doi.org/10.1016/j.cyto.2019.154953

13. Kintscher U, Hartge M, Hess K, Foryst-Ludwig A, Clemenz M, Wabitsch M, et al. T-lymphocyte infiltration in visceral adipose tissue: A primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol [Internet]. 2008 [citado 16/08/2022]; 28(7):1304–10. Disponible en: https://doi.org/10.1161/ATVBAHA.108.165100

14. O’Rourke RW, Kay T, Scholz MH, Diggs B, Jobe BA, Lewinsohn DM, et al. Alterations in T-cell subset frequency in peripheral blood in obesity. Obes Surg [Internet]. 2005 [citado 16/08/2022]; 15(10):1463–8. Disponible en: https://doi.org/10.1381/096089205774859308

15. Connors J, Levy J. COVID-19 and its implications for thrombosis and anticoagulation Tracking. Blood [Internet]. 2020 [citado 16/08/2022]; 23(135):2033-2040. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32635756/

16. Fundación Iberoamericana de Nutrición - FINUT. [citado 16/08/2022]. Fundación Iberoamericana de Nutrición - FINUT. Recuperado el 02 de Marzo de 2021, de https://www.finut.org/obesidad-y-mortalidad-por-covid-19-resultados-de-un-meta-analisis/

17. Martínez V, Viggiano J, Guzmán G ¿Dos pandemias relacionadas? Obesidad y Covid-19. Revista Argentina de Endocrinología y Metabolismo [Internet]. 2020 [citado 16/08/2022]; 57(3):58-63. Disponible en: http://www.raem.org.ar/numeros/2020-vol57/numero-03/raem-57-3-09.

18. Lentz SR. Thrombosis in the setting of obesity or inflammatory bowel disease. Am Soc Hematol Educ Progr [Internet]. 2020 [citado 16/08/2022]; 2020(1):180-187. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142463/

19. Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA [Internet]. 2020 [citado 16/08/2022]; 302(17):1896-902. Disponible en: https://doi.org/10.1001/jama.2009.1583

20. Kassir R. Risk of COVID-19 for patients with obesity. Obes Rev [Internet]. 2020 [citado 16/08/2022]; 21:10-1.

21. Steinberg E, Wright E, Kushner B. In Young Adults with COVID-19, Obesity Is Associated with Adverse Outcomes. West J Emerg Med [Internet]. 2020 [citado 16/08/2022]; 21(4): 752–755. https://doi.org/10.5811/westjem.2020.5.47972

22. Serrano Wiesner MA, Fabara Pino TK, Vélez Vera AJ, Landín Ramírez TM. Morbi-Mortalidad en pacientes obesos infectados por COVID-19. RECIMUNDO [Internet]. 2021 [citado 16/08/2022]; 5(2):71-79. https://doi.org/10.26820/recimundo/5.(2).abril.2021.71-79

23. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidso KW. Presentando características, comorbilidades y resultados entre 5700 pacientes hospitalizados con COVID-19 en el área de la ciudad de Nueva York. JAMA [Internet]. 2020 [citado 16/08/2022]; 323(20):2052-2059. Disponible en: https://doi.org/10.1001/jama.2020.677

24. Palaiodimos L, Kokkinidis DG, Li W, Karamanis D, Ognibene J, Arora S, et al. Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York. Metabolism Clinical and Experimental [Internet]. 2020 [citado 16/08/2022]; 108:154262. Disponible en: https://doi.org/10.1016/j.metabol.2020.154262.

25. Lighter J, Phillips M, Hochman S, Sterling S, Johnson D, Francois F, et al. Obesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 Hospital Admission. Clin Infect Dis. 2020; 71(15):896-897. Disponible en: https://doi.org/10.1093/cid/ciaa415

26. Petrilli CM, Jones SA, Yang J, Rajagopalan H, O'Donnell L, Chernyak Y, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ [Internet]. 2020 [citado 16/08/2022]; 369:m1966. Disponible en: https://doi.org/10.1136/bmj.m1966

27. Dixon AE, Peters U. O efeito da obesidade na função pulmonar. Expert Rev Respir Med [Internet]. 2018 [citado 16/08/2022]; 12(9):755-67. https://doi.org/10.1080/17476348.2018.1506331

28. Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. Clinical and immunologic features in severe and moderate forms of Coronavirus Disease 2019. J Clin Invest [Internet]. 2020 [citado 16/08/2022]; 137244. Disponible en: https://doi.org/10.1172/JCI137244

29. Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, et al. High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation. Obesity (Silver Spring) [Internet]. 2020 [citado 16/08/2022]; 28(7):1195-9. Disponible en: https://doi.org/10.1002/oby.22831

30. Bello-Chavolla OY, Bahena-López JP, Antonio-Villa NE, Vargas-Vázquez A, González-Díaz A, Márquez-Salinas A, et al. Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico. J Clin Endocrinol Metab [Internet]. 2020 [citado 16/08/2022]; 105(8):dgaa346. Disponible en: https://doi.org/10.1210/clinem/dgaa346

Downloads

Published

2022-01-17

How to Cite

1.
Herrera Horta GA, Gutiérrez García Z, Herrera Miranda GL. Obesity as a risk factor for complications in patients with COVID-19. Univ. Méd. Pinareña [Internet]. 2022 Jan. 17 [cited 2025 Apr. 3];19:e827. Available from: https://revgaleno.sld.cu/index.php/ump/article/view/827

Issue

Vol. 19 (2023): Vol.19 (Sistema de Publicación Continua)

Section

Review article

License

Authors who have published with this journal accept the following terms: authors will retain their copyright and guarantee the journal the right of first publication of their work, which will be simultaneously subject to the Creative Commons recognition license that allows third parties to share the work as long as its author is indicated and its first publication is this journal. Authors may adopt other non-exclusive license agreements for the distribution of the version of the published article (e.g., deposit it in an institutional telematic archive or publish it in a monographic volume) provided that the initial publication in this journal is indicated. Authors are permitted and encouraged to disseminate their article using Internet (e.g., in institutional telematic archives or on their website) before and during the submission process, which may lead to interesting exchanges and increased citations of the published work. (See The Effect of Open Access).